Laurus Labs informs about disclosure

10 Feb 2023 Evaluate
Laurus Labs has informed that the United States Food & Drug Administration (USFDA) today completed inspection of our formulations manufacturing facility Unit-2, APSEZ, Atchutapuram, Visakhapatnam, Andhra Pradesh. The inspection was conducted from 6th February, 2023 to 10th February, 2023. It has been issued a Form 483 with two observations. The observations are procedural in nature. The Company will address the observations within stipulated timelines.

The above information is a part of company’s filings submitted to BSE.

Laurus Labs Share Price

512.45 23.40 (4.78%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.